Sinopharm, a state-owned giant in China's coronavirus vaccine development, announced its chairman left the board Tuesday.
The company cited personal reasons for Li Zhiming's resignation, according to a filing for the Hong Kong-listed company. Li Hui, a director and audit committee member of Sinopharm subsidiary China National Medicines Corp. also resigned Tuesday due to personal reasons, a separate filing disclosed. A health worker shows a dose of China's Sinopharm Covid-19 vaccine at a vaccination center in the Jordanian capital Amman on January 13, 2021., a state-owned giant in China's coronavirus vaccine development, announced its chairman left the board Tuesday.
Bakit kaya nag resign? dzbb dzrhnews cnnphilippines ABSCBNNews
Resign before the effective rate hit the new low
Italy’s ‘patient zero’ traced to November 2019
this is terrible news
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
China human rights: European Parliament has concerns over EU-China deal - Business InsiderBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know. Why How long more with all these world devastations caused by China, as nations look on. It’s good to push for improving conditions with China. However, this MEP represents an alliance with 73 of 705 MEPs. 10.3%, not totally insignificant, but also what impact? Plus all this was already known and trade deals are planned years ahead of time
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »